Skip to main content

Advertisement

Log in

Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Feldmeyer L, Mylonas A, Demaria O, et al. Interleukin 23-helper T cell 17 axis as a treatment target for pityriasis rubra pilaris. JAMA Dermatol 2017;153:304–8.

    Article  PubMed  Google Scholar 

  2. Schuster D, Pfister-Wartha A, Bruckner-Tuderman L, Schempp CM. Successful treatment of refractory pityriasis rubra pilaris with secuk-inumab. JAMA Dermatol 2016;152:1278–80.

    Article  PubMed  Google Scholar 

  3. Gauci ML, Jachiet M, Gottlieb J, et al. Successful treatment of type II pityriasis rubra pilaris with secukinumab. JAAD Case Rep 2016;2:462–4.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hanfstingl K, Pekar-Lukacs A, Motz R, Guenova E, Hoetzenecker W. Successful treatment of pityriasis rubra pilaris with ixekizumab. Case Rep Dermatol 2018;10:97–100.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Chowdhary M, Davila U, Cohen DJ. Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris. Case Rep Dermatol 2015;7:46–50.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Craiglow BG, Boyden LM, Hu R, et al. CARD14-associated papu-losquamous eruption: a spectrum including features of psoriasis and pityriasis rubra pilaris. J Am Acad Dermatol 2018;79:487–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Axel-Patrice Villani.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chastagner, M., Hoelt, P., Kanitakis, J. et al. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin. Eur J Dermatol 29, 218–220 (2019). https://doi.org/10.1684/ejd.2019.3502

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2019.3502

Navigation